Literature DB >> 11668352

Risk factors for glucose intolerance in active acromegaly.

A Kreze1, E Kreze-Spirova, M Mikulecky.   

Abstract

In the present retrospective study we determined the frequency of glucose intolerance in active untreated acromegaly, and searched for risk factors possibly supporting the emergence of the diabetic condition. Among 43 patients, 8 (19%; 95% CI: 8-33%) had diabetes mellitus and 2 (5%; 1-16%) impaired glucose tolerance. No impaired fasting glycemia was demonstrable. The frequency of diabetes was on average 4.5 times higher than in the general Slovak population. Ten factors suspected to support progression to glucose intolerance were studied by comparing the frequency of glucose intolerance between patients with present and absent risk factors. A family history of diabetes and arterial hypertension proved to have a significant promoting effect (P<0.05, chi-square test). A significant association with female gender was demonstrated only after pooling our data with literature data. Concomitant prolactin hypersecretion had a nonsignificant promoting effect. In conclusion, the association of active untreated acromegaly with each of the three categories of glucose intolerance (including impaired fasting glycemia, not yet studied in this connection) was defined as a confidence interval, thus permitting a sound comparison with the findings of future studies. Besides a family history of diabetes, female gender and arterial hypertension were defined as additional, not yet described risk factors.

Entities:  

Mesh:

Year:  2001        PMID: 11668352     DOI: 10.1590/s0100-879x2001001100009

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  20 in total

Review 1.  Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.

Authors:  M G Baroni; F Giorgino; V Pezzino; C Scaroni; A Avogaro
Journal:  J Endocrinol Invest       Date:  2015-12-30       Impact factor: 4.256

Review 2.  Growth hormone and its disorders.

Authors:  J Ayuk; M C Sheppard
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

3.  Glucose status in patients with acromegaly receiving primary treatment with the somatostatin analog lanreotide.

Authors:  Elisabeth Couture; Vanina Bongard; Jean-Christophe Maiza; Antoine Bennet; Philippe Caron
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

4.  Acromegaly presenting with diabetic ketoacidosis, associated with retinitis pigmentosa and octreotide-induced bradycardia: a case report and a review of the literature.

Authors:  Cihangir Erem; Halil Onder Ersöz; Kubilay Ukinç; Avni Murat Avunduk; Arif Hacihasanoglu; Mustafa Koçak
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

5.  Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism.

Authors:  Ana Laura Espinosa-de-los-Monteros; Baldomero González; Guadalupe Vargas; Ernesto Sosa; Moisés Mercado
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

Review 6.  Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.

Authors:  Rosario Pivonello; Renata S Auriemma; Ludovica F S Grasso; Claudia Pivonello; Chiara Simeoli; Roberta Patalano; Mariano Galdiero; Annamaria Colao
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 7.  Acromegaly in the elderly patients.

Authors:  Maria Rosaria Ambrosio; Irene Gagliardi; Sabrina Chiloiro; Ana Gonçalves Ferreira; Marta Bondanelli; Antonella Giampietro; Antonio Bianchi; Laura De Marinis; Maria Fleseriu; Maria Chiara Zatelli
Journal:  Endocrine       Date:  2020-02-14       Impact factor: 3.633

8.  Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients.

Authors:  Orsalia Alexopoulou; Marie Bex; Peter Kamenicky; Augustine Bessomo Mvoula; Philippe Chanson; Dominique Maiter
Journal:  Pituitary       Date:  2014-02       Impact factor: 4.107

Review 9.  Medical consequences of acromegaly: what are the effects of biochemical control?

Authors:  Annamaria Colao; Renata S Auriemma; Rosario Pivonello; Mariano Galdiero; Gaetano Lombardi
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

10.  Absence of periodontitis in acromegalic patients.

Authors:  Danilo Lopes Ferreira Lima; Renan Magalhães Montenegro; Anya Pimentel Gomes Fernandes Vieira; Mônica Fiterman Albano; Delane Maria Rego
Journal:  Clin Oral Investig       Date:  2008-09-03       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.